Clinical Trial Update: Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating psilocybin-assisted therapy for treatment-resistant bipolar II depression, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Ii Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Lakshmi N Yatham | Conditions: Bipolar II Depression | Phase 3 | Status: NOT_YET_RECRUITING